Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices.

A national survey of nephrologists found marked heterogeneity and suboptimal guideline implementation in the real-world use of CKD-Mineral Bone Disorder (CKD-MBD) biomarkers, with routine reliance on standard markers but limited availability of newer bone turnover markers.